Annual review of nutrition 34, 237260, doi: 10.1146/annurev-nutr-071812-161201 (2014)
GLP-1s, which include Wegovy, Ozempic, Zepbound and others, are revolutionizing the fight against obesity, all while challenging pharmacy benefit plans to offer sustainable weight-loss solutions for members
However, Retatrutide is still considered an investigational compound , and most information about dosage comes from clinical trials rather than widespread medical use
de la Pea A, Cui X, Geiser J, Loghin C
DOI: 10.1056/NEJMc2207442
Este hito sigue al lanzamiento, en junio de 2024, del primer GLP-1 genrico para diabetes tipo 2, tambin desarrollado por Teva, equivalente a liraglutida 1,8 mg (Victoza)